FR2930644B1 - Procede d'evaluation de la pigmentation - Google Patents

Procede d'evaluation de la pigmentation

Info

Publication number
FR2930644B1
FR2930644B1 FR0852886A FR0852886A FR2930644B1 FR 2930644 B1 FR2930644 B1 FR 2930644B1 FR 0852886 A FR0852886 A FR 0852886A FR 0852886 A FR0852886 A FR 0852886A FR 2930644 B1 FR2930644 B1 FR 2930644B1
Authority
FR
France
Prior art keywords
pigmentation
evaluating
evaluating pigmentation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0852886A
Other languages
English (en)
Other versions
FR2930644A1 (fr
Inventor
Christine Duval
Francoise Bernerd
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LOreal SA
Original Assignee
LOreal SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LOreal SA filed Critical LOreal SA
Priority to FR0852886A priority Critical patent/FR2930644B1/fr
Priority to CA2658074A priority patent/CA2658074C/fr
Priority to KR1020090022255A priority patent/KR101132578B1/ko
Priority to JP2009062725A priority patent/JP6113393B2/ja
Priority to US12/382,384 priority patent/US10612004B2/en
Priority to CN 200910138703 priority patent/CN101538555B/zh
Priority to ES09155394.1T priority patent/ES2596811T3/es
Priority to EP09155394.1A priority patent/EP2103687B1/fr
Publication of FR2930644A1 publication Critical patent/FR2930644A1/fr
Application granted granted Critical
Publication of FR2930644B1 publication Critical patent/FR2930644B1/fr
Priority to JP2016093687A priority patent/JP6240255B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5082—Supracellular entities, e.g. tissue, organisms
    • G01N33/5088—Supracellular entities, e.g. tissue, organisms of vertebrates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0697—Artificial constructs associating cells of different lineages, e.g. tissue equivalents
    • C12N5/0698—Skin equivalents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/09—Coculture with; Conditioned medium produced by epidermal cells, skin cells, oral mucosa cells
    • C12N2502/094—Coculture with; Conditioned medium produced by epidermal cells, skin cells, oral mucosa cells keratinocytes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/13—Coculture with; Conditioned medium produced by connective tissue cells; generic mesenchyme cells, e.g. so-called "embryonic fibroblasts"
    • C12N2502/1323—Adult fibroblasts
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2503/00—Use of cells in diagnostics
    • C12N2503/04—Screening or testing on artificial tissues
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/50—Proteins
    • C12N2533/54—Collagen; Gelatin

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Hematology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Toxicology (AREA)
  • General Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
FR0852886A 2008-03-17 2008-04-29 Procede d'evaluation de la pigmentation Expired - Fee Related FR2930644B1 (fr)

Priority Applications (9)

Application Number Priority Date Filing Date Title
FR0852886A FR2930644B1 (fr) 2008-04-29 2008-04-29 Procede d'evaluation de la pigmentation
CA2658074A CA2658074C (fr) 2008-03-17 2009-03-12 Equivalent de peau pigmentee fonctionnelle
JP2009062725A JP6113393B2 (ja) 2008-03-17 2009-03-16 機能的色素沈着皮膚同等物
US12/382,384 US10612004B2 (en) 2008-03-17 2009-03-16 Functional pigmented skin equivalent
KR1020090022255A KR101132578B1 (ko) 2008-03-17 2009-03-16 기능적 색소화 피부 대체물
CN 200910138703 CN101538555B (zh) 2008-03-17 2009-03-16 功能性色素皮肤等同物
ES09155394.1T ES2596811T3 (es) 2008-03-17 2009-03-17 Equivalente de piel pigmentada funcional
EP09155394.1A EP2103687B1 (fr) 2008-03-17 2009-03-17 Equivalent de peau pigmentée fonctionnelle
JP2016093687A JP6240255B2 (ja) 2008-03-17 2016-05-09 機能的色素沈着皮膚同等物

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0852886A FR2930644B1 (fr) 2008-04-29 2008-04-29 Procede d'evaluation de la pigmentation

Publications (2)

Publication Number Publication Date
FR2930644A1 FR2930644A1 (fr) 2009-10-30
FR2930644B1 true FR2930644B1 (fr) 2012-08-03

Family

ID=39800481

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0852886A Expired - Fee Related FR2930644B1 (fr) 2008-03-17 2008-04-29 Procede d'evaluation de la pigmentation

Country Status (1)

Country Link
FR (1) FR2930644B1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3054449B1 (fr) * 2016-07-29 2018-08-31 L'oreal Equivalent de peau a compartiments dermiques juxtaposes distincts
EP3889247A4 (fr) * 2018-11-30 2022-10-19 Shiseido Company, Ltd. Modèle de pigmentation de la peau et son procédé de production, et procédé d'évaluation du facteur pour le traitement ou la prévention de la pigmentation de la peau

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2879747A1 (fr) * 2004-12-16 2006-06-23 Oreal Procede d'evaluation in vitro du potentiel protecteur contre la photoimmunosuppression ou du caractere photosensibilisant de produits ou de compositions.
FR2903702B1 (fr) * 2006-07-13 2012-10-19 Oreal Equivalent d'epiderme capable de se pigmenter obtenu a partir de cellules de la matrice, procede de preparation et utilisation

Also Published As

Publication number Publication date
FR2930644A1 (fr) 2009-10-30

Similar Documents

Publication Publication Date Title
BRPI0910229A2 (pt) Tetramatos de 4';4'-dioxaspiro espirociclicamente substituídos
BRPI0919058A2 (pt) indicador biológico independente
FI20085488A0 (fi) Älykäs hammasharjamonitorointilaite
BRPI1007939A2 (pt) "identificação de aspectos de consulta"
BRPI0905928A2 (pt) "método de produção de ácido lático"
BRPI0913958A2 (pt) compostos heterocíclicos de 5 e 6 membros
BR112012004593A2 (pt) "método"
DK2157903T3 (da) Fremgangsmåde til iagttagelsesmåling
BRPI0912123A2 (pt) Composições de sal e métodos de produção das mesmas
BRPI0908050A2 (pt) Furo-e tieno[3,2-c]piridinas
BRPI0811828A2 (pt) "método de produção de ácido lático"
BRPI0814416A2 (pt) Método de detecção microbiológica
BRPI0902903A2 (pt) método de avaliação de sinal e aparelho de avaliação de sinal
BRPI0817667A2 (pt) Método de marcação
BRPI0914533A2 (pt) "métodos"
BRPI0923383A2 (pt) método de preparo de pigmentos com polímeros modificados
BRPI0913477A2 (pt) "método para desenvolvimento de marcador diagnóstico"
BRPI0906357A2 (pt) Derivados de oxazepinopirimidona arilamida substituídos
BRPI0921172A2 (pt) cabecote de engate
BRPI1012005A2 (pt) "detecção de defeitos"
GB201013679D0 (en) Analysis of proposed trades
BRPI0912043A2 (pt) métodos de tratamento de doença associada à cinesina meiótica
FR2942270B1 (fr) Procede de determination de la temperature d'un piston
BRPI0810416A2 (pt) Método de hidroformação
BRPI0920426A2 (pt) metodo para prever um ritmo biologico de um individuo.

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 9

PLFP Fee payment

Year of fee payment: 10

PLFP Fee payment

Year of fee payment: 11

PLFP Fee payment

Year of fee payment: 13

ST Notification of lapse

Effective date: 20211205